XNAS: TRAX
First Tracks Biotherapeutics Live Stock Price Today, Share Analysis and Chart
about
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter...
Read More
36.52
0.31
(0.86%)
696.1K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
First Tracks Biotherapeutics Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..